scispace - formally typeset
Journal ArticleDOI

Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.

TLDR
The UPS and autophagy-mediated tau clearance mechanisms are reviewed and the biochemical connections between these two processes are outlined and pharmacological methods that target these degradation systems for the treatment and prevention of AD are discussed.
About
This article is published in Progress in Neurobiology.The article was published on 2013-06-01. It has received 283 citations till now. The article focuses on the topics: Autophagy & Cognitive decline.

read more

Citations
More filters
Journal ArticleDOI

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies

TL;DR: An overview of the proteolytic pathways in neurons is provided, with an emphasis on the UPS, CMA and macroautophagy, and the role of protein quality control in the degradation of pathogenic proteins in neurodegenerative diseases is discussed.
Journal ArticleDOI

Roles of tau protein in health and disease.

TL;DR: It is important to fully understand the range of neuronal functions attributed to tau, since this will provide vital information on its involvement in the development and pathogenesis of disease, and enable determination of which critical molecular pathways should be targeted by potential therapeutic agents developed for the treatment of tauopathies.
Journal ArticleDOI

The role of protein clearance mechanisms in organismal ageing and age-related diseases

TL;DR: Modulation of either proteasome activity or autophagic-lysosomal potential extends lifespan and protects organisms from symptoms associated with proteostasis disorders, suggesting that protein clearance mechanisms are directly linked to ageing and age-associated diseases.
Journal ArticleDOI

Regulation of proteasome activity in health and disease.

TL;DR: The contributions of the proteasome to human pathology, mechanisms that regulate the proteolytic capacity of the Proteasome are described, and strategies to modulate proteasomes function as a therapeutic approach to ameliorate diseases associated with altered UPS function are discussed.
Journal ArticleDOI

Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling

TL;DR: Administration of an agent that activates cAMP–protein kinase A (PKA) signaling led to attenuation of proteasome dysfunction, probably through proteasomesome subunit phosphorylation in vivo, which led to lower levels of aggregated tau and improvements in cognitive performance.
References
More filters
Journal ArticleDOI

Alzheimer's Disease: Genes, Proteins, and Therapy

TL;DR: Evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics and provided discrete biochemical targets for drug screening and development.
Journal ArticleDOI

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

TL;DR: A molecular mechanism for regulation of the mammalian autophagy-initiating kinase Ulk1, a homologue of yeast ATG1, is demonstrated and a signalling mechanism for UlK1 regulation and autophagic induction in response to nutrient signalling is revealed.
Journal ArticleDOI

Methods in Mammalian Autophagy Research

TL;DR: Methods to monitor autophagy and to modulate autophagic activity are discussed, with a primary focus on mammalian macroautophagy.
Journal ArticleDOI

The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction

TL;DR: It is clear now that degradation of cellular proteins is a highly complex, temporally controlled, and tightly regulated process that plays major roles in a variety of basic pathways during cell life and death as well as in health and disease.
Related Papers (5)